Unidade Local De Saude Da Guarda E.P.E.

At Unidade Local De Saude Da Guarda E.P.E., clinical trials in immune system diseases and musculoskeletal diseases focus on conditions such as systemic lupus erythematosus, rheumatoid arthritis, psoriatic arthritis, and Giant Cell Arteritis. These studies are designed to test new therapies and assess whether they can better control inflammation, improve symptoms, and support long-term disease management.

• Evaluating new treatment options for systemic lupus erythematosus and related autoimmune conditions
• Studying therapies for rheumatoid arthritis and psoriatic arthritis to reduce joint and axial disease activity
• Assessing treatment effectiveness and safety in Giant Cell Arteritis
• Exploring improved control of chronic inflammatory disease in rheumatology care

These trials reflect a strong focus on advanced rheumatology research, with the goal of offering better options for patients living with persistent autoimmune and inflammatory disorders.

Research in respiratory tract diseases at this site includes studies in chronic obstructive pulmonary disease and severe asthma with an eosinophilic phenotype. The main purpose is to evaluate new approaches that may reduce flare-ups, improve breathing, and help patients maintain better daily lung function.

• Testing therapies for chronic obstructive pulmonary disease to lower exacerbation rates
• Investigating treatment options for severe asthma with eosinophilic inflammation
• Measuring whether new respiratory therapies can improve symptom control and long-term outcomes
• Supporting better management of chronic airway inflammation

This area highlights ongoing efforts in pulmonology to improve both symptom relief and disease control for people with difficult-to-treat respiratory conditions.

Clinical research in cardiovascular diseases and related inflammatory conditions includes studies in heart failure with preserved or mildly reduced ejection fraction. These trials aim to determine whether new treatments can lower the risk of serious heart events and improve outcomes in patients with systemic inflammation.

• Evaluating therapies for heart failure linked with inflammation
• Assessing whether treatment can reduce cardiovascular complications and improve overall stability
• Studying new options for patients with persistent inflammatory burden and heart disease
• Exploring better ways to support long-term cardiovascular health

The work at Unidade Local De Saude Da Guarda E.P.E. shows a growing interest in the connection between cardiology and inflammation, with research aimed at improving treatment effectiveness in complex heart disease.

Trials in digestive system diseases and bacterial infections examine conditions such as non-alcoholic steatohepatitis and Clostridioides difficile infection, as well as prevention of post-surgical infection. The purpose of this research is to improve disease control, reduce recurrence, and strengthen infection prevention after surgery.

• Studying therapies for non-alcoholic steatohepatitis and liver inflammation
• Testing strategies to prevent recurrent Clostridioides difficile infection
• Evaluating infection prevention after abdominal surgery
• Improving outcomes in gastroenterology and infection control

These studies combine hepatology, infectious disease, and surgical prevention research to address important causes of morbidity in everyday clinical care.

Within neoplasms, the site is involved in studies for unresectable or metastatic HER2+ colorectal cancer. The focus is on evaluating whether new treatment combinations can improve disease control and delay progression in advanced cancer.

• Assessing treatment effectiveness in advanced colorectal cancer
• Studying targeted approaches for HER2-positive disease
• Measuring whether new therapies can extend progression-free survival
• Supporting research in advanced oncology care

This line of research reflects an effort to refine cancer therapy for patients with limited treatment options and more advanced disease.